Effect of prednisone on prostate-specific antigen in patients with hormone-refractory prostate cancer - improvement in performance status, bone pain, and reduction in prostate specific antigen

By Sartor O.   Weinberger M.   Moore A.   Li A.   Figg W.D.  

Urology, Vol. 52, Iss. 2, 1998-08 ,pp. : 252-256

Elsevier

Access to resources Recommend Favorite

Prognostic significance of detection of prostate-specific antigen transcripts in the peripheral blood of patients with metastatic androgen-independent prostatic carcinoma

By Ghossein R.A.   Rosai J.   Scher H.I.   Seiden M.   Zhang Z.-F.   Sun M.   Chang G.   Berlane K.   Krithivas K.   Kantoff P.W.  

Urology, Vol. 50, Iss. 1, 1997-07 ,pp. : 100-105

Elsevier

Access to resources Recommend Favorite

Ki-67 in screen-detected, low-grade, low-stage prostate cancer, relation to prostate-specific antigen doubling time, Gleason score and prostate-specific antigen relapse after radical prostatectomy

By Khatami Ali   Hugosson Jonas   Wang Wanzhong   Damber Jan-Erik  

Scandinavian Journal of Urology and Nephrology, Vol. 43, Iss. 1, 2009-02 ,pp. : 12-18

Informa Healthcare

Access to resources Recommend Favorite

Influence of noncancerous prostatic tissue volume on prostate-specific antigen

By Kojima M.   Troncoso P.   Babaian R.J.  

Urology, Vol. 51, Iss. 2, 1998-02 ,pp. : 293-299

Elsevier

Access to resources Recommend Favorite

Constitutive expression of high levels of prostate-specific antigen in the absence of prostate carcinoma

By Kibel A.S.   Krithivas K.   Shamel L.B.   Kantoff P.W.   DeWolf W.C.  

Urology, Vol. 48, Iss. 5, 1996-11 ,pp. : 741-746

Elsevier

Access to resources Recommend Favorite